Clinical Trial Award – HT942524OCRPCTA
- up to USD$2M over 4 years
- letters of intent due 3 June 2024
- supports rapid implementation of clinical trials
- projects may range from small, proof-of concept trials through large-scale, definitive trials, including early-phase or pilot clinical trials (phase 0, 1, or 1/2)
- preliminary data required
- Document: Funding Opportunity – HT9425-24-OCRP-CTA_GG
Clinical Trial Translational Endpoints Research Award – HT942524OCRPCTTERA
- up to USD$1M over 3 years
- letters of intent due 3 June 2024
- supports correlation of clinical trial-related data with clinical outcomes or responses to therapies
- projects associated with randomized phase 2 or 3 trials encourages
- must include clinical trialist as collaborator
- direct support of clinical trials not allowed
- strictly animal research not allowed
- Document: Funding Opportunity – HT9425-24-OCRP-CTTERA_GG
Investigator Initiated Research Award – HT942524OCRPIIRA
- up to USD$1M over 4 years (single PI) or
- up to USD$1.2M over 4 years (Partnering PIs)
- pre-proposals due 14 May 2024
- supports high impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care
- research aimed at extending the lives of advanced state and recurrent patients is encouraged
- preliminary data required
- clinical trials not allowed
- Document: Funding Opportunity – HT9425-24-OCRP-IIRA_GG
Ovarian Cancer Academy – Early-Career Investigator Award – HT942524OCRPOCAECI
- up to USD$725,000 over 4 years
- pre-proposals due 14 May 2024
- supports addition of new ECRs (<5 years post PhD) to the virtual Ovarian Cancer Academy, providing mentoring, networking collaborations etc
- required a designated mentor, who does not have to be at the same institution
- ECRs whose ability to commit to conducting ovarian cancer research is limited by lack of resources or other overwhelming obstacles are encouraged to apply
- preliminary data required
- clinical trials not allowed
- Document: Funding Opportunity – HT9425-24-OCRP-OCA-ECI_GG
Pilot Award – HT942524OCRPPA
- up to USD$300,000 over 2 years
- pre-proposals due 14 May 2024
- supports innovative, high-risk/high-reward research in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward
- the goals is develop preliminary data – preliminary data not required, but is allowed
- clinical trials not allowed
- Document: Funding Opportunity – HT9425-24-OCRP-PA_GG
Document
Ovarian Cancer Research Program Summary Table – FY24 OCRP PA Reference Table_Final-1
